Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
25.36
+2.79 (12.36%)
At close: Jun 26, 2026, 4:00 PM EDT
25.56
+0.20 (0.79%)
After-hours: Jun 26, 2026, 7:48 PM EDT
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.56 billion as of June 26, 2026. Its market cap has increased by 34,721.76% in one year.
Market Cap
1.56B
Enterprise Value
1.03B
1-Year Change
34,721.76%
Ranking
Category
Stock Price
$25.36
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.56B, an increase of 323.29%. That is a compound annual growth rate of 29.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.56B | 4,147.09% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.64B |
| Zenas BioPharma | 1.63B |
| Aktis Oncology | 1.63B |
| Maravai LifeSciences Holdings | 1.61B |
| ArriVent BioPharma | 1.58B |
| Maze Therapeutics | 1.57B |
| Immunocore Holdings | 1.57B |
| Capricor Therapeutics | 1.53B |